In today’s environment, biopharma commercial strategy, launch success, and product net revenue performance are increasingly shaped by forces beyond the four walls of the organization. Policy volatility, pricing reform, IRA implementation, 340B expansion, state-level legislation, channel complexity, and evolving PBM and payer dynamics are converging to create unprecedented margin pressure.

In this webinar, Consulting Partner Bruce Phelan and Managing Director of Advisory Services Walt Worsham focused on commercial insights for biopharma, providing the must-have elements of a successful biopharma commercial launch plan and translated today’s policy complexity into market access strategies.

• Thursday, June 4th
• 1:00 PM EST